New child-friendly formulations of several important antiretroviral medicines were recently approved by the South African Health Products Regulatory Authority. Thabo Molelekwa asks what this means for children living with HIV in South Africa and how long it will take for these medicines to become widely available.
A recently published survey found that only 76.8% of children surveyed have received all their required childhood vaccines. Elri Voigt unpacks the survey findings and asks whether a recent measles outbreak in Gauteng may be a harbinger of worse outbreaks to come.
Professor Resia Pretorius and her colleagues at the University of Stellenbosch are at the cutting edge of research into one of the most likely causes of long COVID – inflammatory microclots. Adele Baleta spoke to Pretorius about their work.
In 2021, HIV was successfully suppressed in the bodies of around 63% of the close to eight million people living with HIV in South Africa. This is according to recent outputs from Thembisa, the leading mathematical model of HIV in South Africa. With the help of some graphs, Spotlight editor Marcus Low unpacks this and other key model outputs.
Earlier this month Cape Town-based vaccine company Afrigen announced a formal collaboration with the United States National Institute of Allergy and Infectious Diseases’ (NIAID’s) Vaccine Research Centre. Catherine Tomlinson unpacks what this deal may mean for local production of vaccines for COVID-19 and other diseases.
Tuberculosis can be challenging to diagnose in children, especially very young children. This is because it is difficult for them to cough up the sputum required by gold standard molecular tests and because they have fewer TB organisms in their sputum than adults. X-ray screening may be part of the solution, but it has shortcomings. Following some interesting recent study findings, Tiyese Jeranji asks what role lung ultrasound may have in improving TB detection in kids.
A cancer patient navigator’s work days can be filled with both hope and hell, but their role can make all the difference when someone receives what can be the most devastating news of their lives. Ufrieda Ho spent some time with a cancer patient navigator for a glimpse of what it takes to do this job.
Based on figures from the national Department of Health over 107 000 non-emergency or elective surgeries were put on hold during the COVID-19 pandemic. But challenges in addressing surgical backlogs were there before COVID-19. Alicestine October asked some local experts how surgical care can be better coordinated in South Africa.
Elective surgery is often performed on injuries or for conditions considered less life-threatening and some patients can wait up to two years for their procedure, which will often be scheduled and then cancelled when someone with a more serious medical emergency takes their spot on the list. This takes a huge emotional and financial toll on these patients and their families. Alicestine October reports.
Indications are that the virus that causes COVID-19 is going to continue evolving and escaping the protection against infection people already have. Researchers are working on next-generation vaccines tailored to fight off specific versions of the virus, like the Omicron sub-lineages BA.4 and BA.5. But can these new vaccines be tested and produced fast enough to keep up with the rapidly changing virus? Aisha Abdool Karim asked some local experts.
In January, the computer system at the George Mukhari Hospital broke down with serious implications for patient care. In an effort to improve service delivery and the quality of healthcare services, the Gauteng Department of Health in 2020, announced that it would be upgrading its information technology system. Thabo Molelekwa looked at the progress of the new system in light of the ongoing challenges at the George Mukhari Hospital.
Omicron and its sub-variants have been dominating new surges of SARS-CoV-2 infections around the world and were behind South Africa’s fifth wave. The BA.4 and BA.5 sub-lineages unveiled yet more surprises about the evasive nature of these ever-emerging forms of SARS-CoV-2. They also hold clues for what to expect next and how to prepare. Aisha Abdool Karim reports.